COPD_A_233834 3053..3061
暂无分享,去创建一个
J. Pépin | F. Maltais | H. Coxson | N. Alméras | I. Vivodtzev | D. Viglino | Mickaël Martin | Johanna Despres | J. Despres
[1] J. Pépin,et al. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease , 2018, Scientific Reports.
[2] Yong‐ho Lee,et al. Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007–2010 , 2018, International journal of chronic obstructive pulmonary disease.
[3] A. Lonardo,et al. Clinical relevance of liver histopathology and different histological classifications of NASH in adults , 2018, Expert review of gastroenterology & hepatology.
[4] E. Tapper,et al. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD , 2018, Nature Reviews Gastroenterology & Hepatology.
[5] E. Wouters. Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease , 2017, Annals of the American Thoracic Society.
[6] K. Onishi. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. , 2017, Journal of cardiology.
[7] N. Habib,et al. Non-alcoholic fatty liver disease: A sign of systemic disease. , 2017, Metabolism: clinical and experimental.
[8] J. Pépin,et al. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease , 2017, European Respiratory Journal.
[9] A. Lonardo,et al. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk , 2017, Advances in Therapy.
[10] G. Washko,et al. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy , 2017, International journal of chronic obstructive pulmonary disease.
[11] A. Lonardo,et al. The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.
[12] K. Clément,et al. Nonalcoholic fatty liver disease and obstructive sleep apnea. , 2016, Metabolism: clinical and experimental.
[13] M. Hunink,et al. Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography , 2015, The American Journal of Gastroenterology.
[14] E. Bjornsson,et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.
[15] J. Soriano,et al. Impact of Obesity on the Clinical Profile of a Population-Based Sample with Chronic Obstructive Pulmonary Disease , 2014, PloS one.
[16] T. Arisawa,et al. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.
[17] S. Hung,et al. Exhaled Nitric Oxide Predicts Eosinophilic Airway Inflammation in COPD , 2014, Lung.
[18] Kazuaki Chayama,et al. Nonalcoholic fatty liver disease and cardiovascular disease. , 2014, Current pharmaceutical design.
[19] K. Clément,et al. Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. , 2014, Chest.
[20] C. Byrne,et al. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. , 2014, World journal of gastroenterology.
[21] J. Dufour,et al. The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. , 2014, Clinics in liver disease.
[22] Yoshito Itoh,et al. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , 2014, World journal of gastroenterology.
[23] M. Taniai,et al. Characteristics and diagnosis of NAFLD/NASH , 2013, Journal of gastroenterology and hepatology.
[24] M. Hsieh,et al. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population‐based study , 2013, European journal of clinical investigation.
[25] Rohit Loomba,et al. The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.
[26] N. Vozoris,et al. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. , 2012, Canadian respiratory journal.
[27] L. Edwards,et al. Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.
[28] Christopher E Brightling,et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. , 2011, American journal of respiratory and critical care medicine.
[29] Josep Roca,et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes , 2010, Thorax.
[30] Edwin K Silverman,et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.
[31] Udo Hoffmann,et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study , 2010, Hepatology.
[32] David H. Kim,et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. , 2010, AJR. American journal of roentgenology.
[33] T. Poynard,et al. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience. , 2008, Journal of gastrointestinal and liver diseases : JGLD.
[34] W. MacNee,et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.
[35] S. Curley,et al. Comparison of CT methods for determining the fat content of the liver. , 2007, AJR. American journal of roentgenology.
[36] N. Anthonisen,et al. Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.
[37] Sang Won Lee,et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.
[38] R. Ross,et al. Protocol for measurement of liver fat by computed tomography. , 2006, Journal of applied physiology.
[39] S. Suissa,et al. Cardiovascular morbidity and mortality in COPD. , 2005, Chest.
[40] R. Pistelli,et al. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity , 2003, European Respiratory Journal.
[41] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[42] R. Brasch,et al. Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. , 2001, AJR. American journal of roentgenology.
[43] W M Thompson,et al. CT appearance of focal fatty infiltration of the liver. , 1982, AJR. American journal of roentgenology.
[44] Brian T Palmisano,et al. Role of Estrogens in the Regulation of Liver Lipid Metabolism. , 2017, Advances in experimental medicine and biology.
[45] Xingxing Sun,et al. Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[46] A. Schols,et al. Central fat and peripheral muscle: partners in crime in chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.